Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 333 (RNA5SP333) is a pseudogene identified in the human genome and part of a large family of 5S ribosomal RNA pseudogenes[2][4][6]. Unlike functional 5S ribosomal RNA genes, which code for an RNA that is a structural component of the large (60S) ribosomal subunit and is essential for ribosome assembly and function[1][3], pseudogenes such as RNA5SP333 contain sequence similarity to functional 5S rRNA genes but have accumulated mutations that prevent transcription or produce non-functional transcripts[2][4][6]. Pseudogenes are generally considered non-coding, do not encode proteins or functional RNA products, and are not direct drug targets[4][6]. There is no evidence that RNA5SP333 is directly involved in any disease, interacts with drugs, or serves as a clinically relevant biomarker. Its nomenclature and identity as a pseudogene conform to the standards set by the HUGO Gene Nomenclature Committee (HGNC)[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 333 (RNA5SP333).